Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Marc Lessmann"'
Autor:
Markus Wilke, Dirk Möller, Martin Thummet, Jörn Grundmann, Marc Lessmann, Matthias Böhm, Johannes Richter, Christian Weidermann, Peter Gröppel, Lars Kühn, Stefan Moldenhauer, Markus Klöpzig, Mercedes Herranz-Garcia, Andreas Schröter, Mykhaylo Filipenko, Arestid Spangolo, Peter van Hasselt, Michael Frank, Thomas Gleixner, Kerstin Häse
Publikováno v:
Superconductor Science and Technology. 33:054002
The reduction of emission is a key goals for the aviation industry. One enabling technology to achieve this goal, could be the transition from conventional gas turbines to hybrid-electric drive trains. However, the requirements concerning weight and
Autor:
André Pohlmann, Thomas Finocchiaro, Kay Hameyer, Andreas Fritschi, Marc Leßmann, Ulrich Steinseifer
Publikováno v:
Mechatronics. 23:222-226
In industrialized countries cardiovascular diseases are the major cause of death. Beside heart transplants, which are a limited option due to the limited number of available human donor hearts, Total Artificial Hearts (TAHs) are the only therapy avai
Publikováno v:
COMPEL - The international journal for computation and mathematics in electrical and electronic engineering. 31:1067-1076
PurposeThe purpose of this paper is to describe a design process for a drive of a ventricular assist device (VAD) under the consideration of constraints given by the application. In this case, these constraints are the possibility to implant the VAD
Publikováno v:
Journal of Electrical Engineering and Technology. 7:193-199
Worldwide cardiovascular diseases are the major cause of death. Aside from heart transplants, which are limited due to the availability of human donor hearts, artificial hearts are the only therapy available for terminal heart diseases. For various r
Autor:
André Pohlmann, Thomas Finocchiaro, Andreas Fritschi, Marc Lessmann, Kay Hameyer, Ulrich Steinseifer, Thomas Schmitz-Rode
Publikováno v:
Archives of Electrical Engineering. 60:169-178
Drive optimisation of a pulsatile Total Artificial HeartTotal Artificial Hearts (TAHs) are required for the therapy of terminal heart diseases as heart transplants are only a limited option due to the available number of donor hearts. For implantatio
Publikováno v:
IEEE Transactions on Magnetics. 47:1166-1169
Worldwide cardiovascular diseases are the major cause of death. Together with the limited heart transplants due to the limited number of donor hearts, artificial hearts (AH) are the only therapy available for terminal heart diseases. Starting from th
Publikováno v:
COMPEL - The international journal for computation and mathematics in electrical and electronic engineering. 29:1184-1194
Purpose – A fundamental disadvantage of three‐dimensional finite element (FE) simulations is high computational cost when compared to two‐dimensional models. The purpose of this paper is to present an approach to minimize the computation time b
Autor:
Thomas Finocchiaro, Marc Lessmann, Mehdi Behbahani, Thomas Schmitz-Rode, Steffen Leonhardt, Stefanie Heinke, Marco Laumen, Kay Hameyer, Marek Behr, Ulrich Steinseifer
Publikováno v:
Biomedizinische Technik/Biomedical Engineering. 54:269-281
Cardiovascular diseases are a major cause of death worldwide. If medical treatments fail to restore adequate blood flow in a patient, mechanical support is needed. To date, many different types of blood pumps have been developed, but only few are cli
Publikováno v:
IET Science, Measurement & Technology. 2:499-505
Although total artificial hearts (TAHs) available on today's market can sustain a patient's life, their quality of life does not reach the potential of a donor heart transplant. The main reasons are device size and weight, as well as durability and t
Autor:
Thomas Schmitz-Rode, Kay Hameyer, Thomas Butschen, Marc Lessmann, Thomas Finocchiaro, P.B. Kwant, Ulrich Steinseifer
Publikováno v:
IEEE Transactions on Magnetics. 44:678-681
Total artificial hearts (TAHs), available in today's market, have the disadvantage of wear-prone components. Thus, their expectation of life is limited and the devices can only be used for temporary and not destination therapy. Durability- and wear-f